AveXis Expands Clinical Testing of Gene Therapy, AVXS-101, to Include Milder SMA Types – SMA News Today
SMA News Today |
AveXis Expands Clinical Testing of Gene Therapy, AVXS-101, to Include Milder SMA Types
SMA News Today AveXis plans to launch clinical trials of its gene therapy AVXS-101 in a wider range of spinal muscular atrophy (SMA) patients — mirroring the company's belief that the treatment may also benefit those with milder forms of the disease. The planned … Insider Selling: AveXis Inc (AVXS) Insider Sells 15000 Shares of Stock AveXis Inc. (AVXS) Soars 5.05% on January 18 AveXis Inc (AVXS) VP James J. Litalien Sells 5000 Shares |
